This online video explores the profound challenges and strategies for addressing co-occurring severe mental illness (SMI) and opioid use. Led by Mark H. Broadhead, MD, this session delves into the physiological and psychological impacts of fentanyl use, its effects on medication efficacy, and the complexities of treatment. Participants will gain insights into evidence-based strategies for integrated care, contingency management, and the importance of connectivity in therapeutic interventions.
Learning Objectives:
- Analyze the effects of fentanyl and opioid use on individuals with co-occurring severe mental illness (SMI) and how these substances influence overall mental health.
- Evaluate the impact of opioid and fentanyl use on the efficacy and management of medications for severe mental illness.
- Develop and refine intervention strategies and counseling techniques to address the complexities of treating clients with dual diagnoses involving opioid use and SMI.
Presented by: Mark Broadhead, M.D.
Dr. Broadhead received his medical degree from University of Nevada School of Medicine in 1986 and has been in practice for more than 30 years.
Funding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.